Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Giuseppe, Comella"'
Autor:
Maria Rosaria Rubulotta, Pasquale Comella, G. Iodice, R. Thomas, Giuseppe D'Aiuto, Giuseppe Comella, V. De Rosa, G. Botti, M. Di Bonito, Giuseppe Frasci
Publikováno v:
British Journal of Cancer
The present study aimed at evaluating whether a weekly cisplatin, epirubicin, and paclitaxel (PET) regimen could increase the pathological complete response (pCR) rate in comparison with a tri-weekly epirubicin and paclitaxel administration in locall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54015373490ef6bcadb643e56d08cae
http://europepmc.org/articles/PMC2360722
http://europepmc.org/articles/PMC2360722
Autor:
Erminia Ferrario, Antonio Ardizzoni, Enrico Aitini, Giuseppe Schieppati, Bruno Massidda, Maria Di Bartolomeo, Giovanni Marini, Arpine Gevorgyan, Graziella Pinotti, Luigi Mariani, Giuseppe Comella, Giovanni Cicero, Roberto Buzzoni, Emilio Bajetta, Dotti Katia, Roberto Bordonaro, Nicoletta Zilembo, Anna Maria Bochicchio, Salvatore Palazzo
Publikováno v:
Oncology. 71:341-346
Objective: Combination therapies of fluorouracil (FU) with irinotecan (CPT-11) and docetaxel plus cisplatin have been proven to be active in metastatic gastric cancer. In this paper, we present the results of a phase III trial in which these two comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::655b3ef82f8aea30226af8f502fc596c
https://doi.org/10.1159/000108575
https://doi.org/10.1159/000108575
Autor:
G. Botti, M. Di Bonito, G. Romano, Giuseppe Comella, Maria Rosaria Rubulotta, R. Thomas, Giuseppe Frasci, Giuseppe D'Aiuto, Massimiliano D’Aiuto, Pasquale Comella
Publikováno v:
Annals of Oncology. 16:1268-1275
Purpose: The present study aimed to define the antitumor activity of eight cisplatin – epirubicin – paclitaxel (PET) weekly cycles with granulocyte colony-stimulating factor (G-CSF) support in patients with large operable breast cancer. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54482518e389433a32169c922ae43d1
https://doi.org/10.1093/annonc/mdi256
https://doi.org/10.1093/annonc/mdi256
Autor:
Giuseppe Comella, Giuseppe Frasci, Massimiliano D’Aiuto, R. Thomas, Giuseppe D'Aiuto, Renato Giordano, Gerardo Botti, Vincenzo De Rosa, Pasquale Comella, Paolo Vallone, Liliana Lapenta, Maurizio Di Bonito, Roberta D’Aniello
Publikováno v:
Oncology. 68:391-397
Purpose: To evaluate the feasibility and activity of combination treatment with docetaxel (DTX) and irinotecan (CPT-11), given together every other week, combined with filgrastim support, in anthracycline- and paclitaxel-pretreated breast cancer (BC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e79507072b6f8d5b490ee3b79bbf25c
https://doi.org/10.1159/000086980
https://doi.org/10.1159/000086980
Autor:
Pasquale Comella, Roberta D’Aniello, Renato Giordano, Giuseppe Comella, Cosimo Brunetti, Massimiliano D’Aiuto, D Muci, Ignazio Carreca, Giuseppe DeCataldis, Sergio Palmeri, Anna Russo, Giuseppe Frasci
Publikováno v:
Oncology. 68:223-229
Purpose: The present study was aimed at defining the antitumor activity of the cisplatin-epirubicin-paclitaxel (PET) weekly administration with granulocyte colony-stimulating factor (G-CSF) support in chemonaive small-cell lung cancer patients with e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15ce51964206efaf2ad45b7bc9404316
https://doi.org/10.1159/000086778
https://doi.org/10.1159/000086778
Autor:
G. Fiorentini, M Marangolo, Gerardo Rosati, C. Ceravolo, E. Piazza, Andrea Mambrini, D Zamagni, C. Rabbi, M. Cantore, L. Miserocchi, G Luppi, R. Caudana, A. Del Freo, Giuseppe Comella
Publikováno v:
Journal of Chemotherapy. 16:589-594
Gemcitabine is considered the gold standard treatment for unresectable pancreatic adenocarcinoma. Intra-arterial drug administration had shown some interesting results in small phase II studies. In this study, patients were randomly assigned to recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41247e772dc7167cb2d7eee901bfc50e
https://doi.org/10.1179/joc.2004.16.6.589
https://doi.org/10.1179/joc.2004.16.6.589
Publikováno v:
Current Opinion in Oncology. 16:225-230
PURPOSE OF REVIEW The purpose of this review is to provide an update on novel medical treatments for head and neck cancer. RECENT FINDINGS Despite the continuing introduction of new cytotoxic agents, such as antimetabolites (capecitabine, pemetrexed)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004b3b2b9790fb7f9e29917e07d90b3b
https://doi.org/10.1097/00001622-200405000-00006
https://doi.org/10.1097/00001622-200405000-00006
Autor:
Liliana Lapenta, Giuseppe Comella, Francesco Izzo, A. Avallone, Francesco Fiore, V. De Rosa, Rossana Casaretti, Pasquale Comella
Publikováno v:
Annals of Oncology. 13:1874-1881
Background: Oxaliplatin (OXA) and irinotecan (IRI) are active drugs in first-line as well as second-line treatment of advanced colorectal cancer patients, their toxicity profiles are not overlapping, and both drugs have shown synergism with folinic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9417154482c385cbea87370b0b9f7d4
https://doi.org/10.1093/annonc/mdf307
https://doi.org/10.1093/annonc/mdf307
Autor:
F. Rivellini, Giuseppe Comella, Luigi Maiorino, Luigi De Lucia, Pasquale Comella, Giuseppe De Cataldis, Antonio Avallone, Rossana Casaretti, M. Biglietto, Liberato Di Lullo
Publikováno v:
Oncology. 60:127-133
Purpose: To define the maximum tolerated dose (MTD) of irinotecan (CPT-11) given on days 1 and 8 with mitomycin C (MMC) given on day 1 in a monthly cycle, and to assess the toxicity and activity of this regimen in patients with previously treated col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fafa14c4538c5185f74ef79b527a3cdd
https://doi.org/10.1159/000055309
https://doi.org/10.1159/000055309
Autor:
Giuseppe Comella, Pasquale Comella, Cosimo Brunetti, Giuseppe Frasci, Ignazio Carreca, Sergio Palmeri, D. Muci, G DeCataldis, Antonio Russo, G.P. Nicolella, N. Panza, Michele Di Natale, Francovito Piantedosi
Publikováno v:
British Journal of Cancer
The present study was aimed at defining the antitumour activity of the cisplatin-paclitaxel-topotecan (CPT) weekly administration with G-CSF support in chemo-naive SCLC patients with extensive disease (ED-SCLC). Chemonaive ED-SCLC patients received c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e9c834ff6ca0001b885430ac82f420
https://doi.org/10.1054/bjoc.2001.1741
https://doi.org/10.1054/bjoc.2001.1741